Furestem-OA (allogeneic umbilical cord blood-derived mesenchymal stem cells) / Kangstem Biotech - LARVOL DELTA

Long-Term Follow-up Study of Subjects With Knee Osteoarthritis Who Had Administered FURESTEM-OA Kit Inj. in K0701 Study (clinicaltrials.gov) - P=N/A | N=58 | Not yet recruiting | Sponsor: Kang Stem Biotech Co., Ltd.

New trial • Immunology • Osteoarthritis • Pain • Rheumatology

Evaluate Safety and Explore Efficacy of FURESTEM-OA Kit Inj. in Patients With Knee Osteoarthritis (clinicaltrials.gov) - P1/2 | N=68 | Not yet recruiting | Sponsor: Kang Stem Biotech Co., Ltd.

New P1/2 trial • Immunology • Osteoarthritis • Pain • Rheumatology

Kangstem Biotech secures 39 billion won in funds 'green light'… Clinical speed 'UP' [Google translation] (docdocdoc.co.kr) - "Kang Stem Biotech, which is about to make an offering for public offering on the 18th, has received an active response from existing investors, and a green light has been put on raising funds through capital increase....Kangstem Biotech plans to invest KRW 20.8 billion for PureStem-AD, KRW 7 billion for PureStem-RA, and KRW 9.9 billion for PureStem-OA....Kangstem Biotech is working on the second phase 3 clinical trial (FURIN) of PureStem-AD, a treatment for atopic dermatitis, which was approved by the Ministry of Food and Drug Safety in May."

Financing • New P3 trial • Atopic Dermatitis • Immunology • Osteoarthritis

Kang Stem Biotech, Osteoarthritis Treatment Clinical Phase 1/2a Test Plan Application [Google translation] (Pharm News) - "Single-dose, step-by-step dose escalation and titration to evaluate the safety and exploratory efficacy of 'FURESTEM-OA Kit Inj.' in patients with knee osteoarthritis. It announced that it had applied for a dose search, phase 1/2a clinical trial plan (IND) to the Ministry of Food and Drug Safety on the 30th...Phase 1 is for confirming the Maximum Tolerated Dose (MTD) and evaluating adverse reactions according to the Dose Limiting Toxicities (DLTs) evaluation, and Phase 2a is for confirming the Recommended Phase 2 Dose (RP2D) and exploratory It is conducted for the purpose of evaluating the efficacy..."

New P1/2 trial • CNS Disorders • Osteoarthritis • Pain